Orphan designation: Exidavnemab Treatment of multiple system atrophy, 20/06/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 July 2025 - 11:30

Orphan designation: Exidavnemab Treatment of multiple system atrophy, 20/06/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3075

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters